title: Beta-blockade should not be among several choices for initial therapy of hypertension.
authors.affiliation: Hypertension Clinic, Department of Medicine, Groote Schuur Hospital and Hatter Institute, Cape Heart Centre, University of Cape Town Faculty of Health Sciences, Observatory, Cape Town, 7925, South Africa. lionel.opie@uct.ac.za
authors.forename: Lionel H
authors.initials: LH
authors.lastname: Opie
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000145:classification; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced; D005060:Europe; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents